top of page

MBrace Therapeutics Raises $85 Million Series B Financing to Advance Oncology Pipeline of Innovative

– Oversubscribed Series B round led by TPG includes prominent group of new and existing investors, bringing total raised to-date to over $110 million

– Funding supports rapid clinical development of targeted ADC therapeutics in difficult-to-treat cancers

– Chris LeMasters joins as Independent Board Member, bringing 25 years of biotech experience

0 views0 comments

Recent Posts

See All

아스트라제네카, 12억 달러에 중국 그레이스엘바이오 인수

- CAR-T 세포치료제 분야 파이프라인 강화 자가 CAR-T는 신체 면역반응의 핵심 부분 인 환자의 면역 T세포를 질병을 유발하는 세포를 표적으로 삼도록 재(再) 프로그래밍하여 만든 세포 치료법이다. 그라셀의 패스트카 플랫폼(FasTCAR


bottom of page